|
Index of reports
> Death (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dantrium (Dantrolene) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Dantrium side effects in 48 year old male
Reported by a physician from Japan on 2012-06-15
Patient: 48 year old male
Reactions: Atelectasis, Dyspnoea, Respiratory Failure, Hypercapnia, Respiratory Fatigue, Sputum Retention, Vital Capacity Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Botox
Dosage: 240 units, single
Indication: Scoliosis
Start date: 2012-06-05
End date: 2012-06-05
Botox
Dosage: unk
Start date: 2006-12-14
End date: 2006-12-14
Lioresal
Administration route: Oral
Indication: Muscle Spasms
End date: 2012-06-07
Dantrium
Administration route: Oral
Indication: Muscle Spasms
End date: 2012-06-07
Diazepam
Administration route: Oral
Indication: Muscle Spasms
End date: 2012-06-07
Other drugs received by patient: Lansoprazole; Neuzym; Cefazolin Sodium; Mucosta; Mucodyne; Gasmotin; Hokunalin:tape; Sennoside
Possible Dantrium side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-04-02
Patient: male
Reactions: Disseminated Intravascular Coagulation, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dantrium
Other drugs received by patient: Probitor; Methylprednisolone Sodium Succinate; Clindamycin; Dopaston; Ceftazidime
Possible Dantrium side effects in male
Reported by a consumer/non-health professional from Netherlands on 2012-02-27
Patient: male
Reactions: Pneumonia, Disseminated Intravascular Coagulation, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dantrium
Other drugs received by patient: Methylprednisolone Sodium Succinate; Dopaston; Clindamycin; Ceftazidime
Possible Dantrium side effects in 75 year old female
Reported by a pharmacist from Japan on 2012-02-14
Patient: 75 year old female
Reactions: Hepatitis Fulminant
Adverse event resulted in: death
Drug(s) suspected as cause:
Dantrium
Indication: Neuroleptic Malignant Syndrome
Start date: 2011-03-15
End date: 2011-03-15
Pepcid
Start date: 2011-03-15
End date: 2011-03-17
Other drugs received by patient: Dopamine Hydrochloride; Albuminar; Cefepime Hydrochloride; Dalteparin Sodium; Midazolam; Fentanyl Citrate
Possible Dantrium side effects in 75 year old female
Reported by a pharmacist from Japan on 2011-12-19
Patient: 75 year old female
Reactions: Hepatitis Fulminant
Adverse event resulted in: death
Drug(s) suspected as cause:
Pepcid
Start date: 2011-03-15
End date: 2011-03-17
Dantrium
Indication: Neuroleptic Malignant Syndrome
Start date: 2011-03-15
End date: 2011-03-15
Other drugs received by patient: Fentanyl Citrate; Midazolam; Albuminar; Dalteparin Sodium; Cefepime Hydrochloride; Dopamine Hydrochloride
|
